IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP V, LLC

Q1 2026 Holdings

Filed 2026-05-07 | 3 holdings | $401.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rapport Therapeutics, Inc.(RAPP)COM75383L102$223.3M7,135,23355.7%
Septerna, Inc.(SEPN)COM81734D104$149.4M6,215,59137.2%
Maze Therapeutics, Inc.(MAZE)COM578784100$28.4M950,8007.1%